Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-08 Sale |
2024-08-12 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,197 | $1,085 | $5,636,346 | 60,553 (Indirect Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 4:02 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
8,037 | $950.35 | $7,637,954 | 62,458 (Indirect Direct) |
View |
| 2023-08-22 Sale |
2023-08-23 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
11,665 | $840.98 | $9,810,082 | 94,289 (Indirect Direct) |
View |
| 2022-08-05 Sale |
2022-08-08 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,782 | $612.61 | $14,569,134 | 63,214 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-18 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
17,521 | $519.46 | $9,101,460 | 111,701 (Indirect Direct) |
View |
| 2020-05-11 Sale |
2020-05-11 4:39 pm |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,305 | $569.52 | $3,021,289 | 51,174 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-16 Tax Withholding |
2024-12-18 4:02 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
304 | $730.81 | 59,283 (Direct) |
View |
| 2024-12-09 Tax Withholding |
2024-12-10 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
466 | $787 | 59,587 (Direct) |
View |
| 2024-08-13 Gift |
2024-08-14 4:01 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
500 | $0 | 60,053 (Direct) |
View |
| 2024-08-12 Gift |
2024-08-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
900 | $0 | 60,553 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-06 4:03 pm |
N/A 2025-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,638 | $0 | 111,650 (Direct) |
View |
| 2024-08-02 Exercise |
2024-08-06 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
23,638 | $555.67 | 111,650 (Direct) |
View |
| 2024-08-02 Tax Withholding |
2024-08-06 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
18,441 | $1,093 | 111,650 (Direct) |
View |
| 2024-02-26 Gift |
2024-02-28 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
1,020 | $0 | 61,438 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
30,750 | $0 | 70,495 (Direct) |
View |
| 2024-02-02 Tax Withholding |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
22,713 | $956.65 | 70,495 (Direct) |
View |
| 2024-02-02 Exercise |
2024-02-06 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
30,750 | $399.66 | 70,495 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:05 pm |
N/A 2033-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
3,912 | $0 | 65,517 (Direct) |
View |
| 2023-12-08 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
809 | $843.79 | 65,517 (Direct) |
View |
| 2023-12-11 Tax Withholding |
2023-12-12 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
725 | $844.09 | 65,517 (Direct) |
View |
| 2023-11-10 Gift |
2023-11-14 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
400 | $0 | 63,139 (Direct) |
View |
| 2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,000 | $0 | 94,289 (Direct) |
View |
| 2023-08-21 Exercise |
2023-08-23 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,000 | $399.66 | 94,289 (Direct) |
View |
| 2023-08-21 Tax Withholding |
2023-08-23 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
38,335 | $833.39 | 94,289 (Direct) |
View |
| 2022-12-16 Option Award |
2022-12-20 4:08 pm |
N/A 2032-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
5,164 | $0 | 67,582 (Direct) |
View |
| 2022-11-08 Gift |
2022-12-13 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
330 | $0 | 62,418 (Direct) |
View |
| 2022-12-09 Tax Withholding |
2022-12-13 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
466 | $753.28 | 62,418 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
95,000 | $270.43 | 63,214 (Direct) |
View |
| 2022-08-04 Exercise |
2022-08-08 4:11 pm |
N/A 2023-12-13 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
95,000 | $0 | 63,214 (Direct) |
View |
| 2022-08-04 Tax Withholding |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
71,218 | $613 | 63,214 (Direct) |
View |
| 2022-02-18 Gift |
2022-08-08 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
335 | $0 | 63,214 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
753 | $664.34 | 63,527 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:35 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
15,420 | $0 | 76,774 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-06 4:10 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
72,500 | $0 | 61,354 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
72,500 | $179.13 | 61,354 (Direct) |
View |
| 2021-11-29 Gift |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
4,605 | $0 | 61,354 (Direct) |
View |
| 2021-12-03 Tax Withholding |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,352 | $632.45 | 61,354 (Direct) |
View |
| 2021-05-14 Tax Withholding |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
34,979 | $516.69 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
52,500 | $0 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
40,000 | $179.13 | 111,701 (Direct) |
View |
| 2021-05-14 Exercise |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $52.03 | 111,701 (Direct) |
View |
| 2021-02-25 Gift |
2021-05-18 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
435 | $0 | 111,701 (Direct) |
View |
| 2020-12-09 Option Award |
2020-12-11 4:05 pm |
N/A 2030-12-09 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
19,188 | $0 | 57,115 (Direct) |
View |
| 2020-02-26 Gift |
2020-12-11 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
750 | $0 | 57,115 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:39 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $0 | 51,174 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-11 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
12,500 | $52.03 | 51,174 (Direct) |
View |
| 2020-05-08 Tax Withholding |
2020-05-11 4:39 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
7,195 | $560.67 | 51,174 (Direct) |
View |